Table 3.

Comparisons of the eight item-scale of health survey (SF-36) for patients before and after treating with bumetanide

Variables	Mean±SD		P
	Baseline (n=9)	After 4 Months (n=9)
Social functioning	85.4±7.82	90.0±7.38	0.12
Physical functioning	44.1±6.84	46.7±7.14	0.25
Role – physical	100±0.01	100±0.01	0
General health	40.0±5.6	44.0±7.2	0.03
Mental health 26	32.7±9.6	70.5±15.3	0.001
Vitality	96.3±4.8	96.3±4.8	0
Role emotional	34.5±6.5	48.9±6.6	0.002
Bodily pain	33.6±8.8	67.8±15.4	0.001
Total	53.7±28.8	70.5±21.3	0.03

P-values were calculated using the Wilcoxon matched-pairs signed-rank test; SF-36 containing 36 questions that include 8 subscales.